Mannkind (MNKD) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.38% |
| Dec 31, 2025 | 2.25% |
| Sep 30, 2025 | 19.44% |
| Jun 30, 2025 | -2.05% |
| Mar 31, 2025 | 4.33% |
| Dec 31, 2024 | 9.50% |
| Sep 30, 2024 | 15.90% |
| Jun 30, 2024 | 64.98% |
| Mar 31, 2024 | 41.12% |
| Dec 31, 2023 | 27.36% |
| Sep 30, 2023 | 51.37% |
| Jun 30, 2023 | 26.91% |
| Mar 31, 2023 | 26.31% |
| Dec 31, 2022 | 9.68% |
| Sep 30, 2022 | 40.27% |
| Jun 30, 2022 | -3.93% |
| Mar 31, 2022 | 6.97% |
| Dec 31, 2021 | 40.24% |
| Sep 30, 2021 | 7.79% |
| Jun 30, 2021 | -0.39% |
| Mar 31, 2021 | 55.05% |
| Dec 31, 2020 | 2.55% |
| Sep 30, 2020 | 9.74% |
| Jun 30, 2020 | -10.02% |
| Mar 31, 2020 | -20.30% |
| Dec 31, 2019 | -24.37% |
| Sep 30, 2019 | -29.44% |
| Jun 30, 2019 | -28.01% |
| Mar 31, 2019 | -0.70% |
| Dec 31, 2018 | 0.10% |
| Sep 30, 2018 | -35.53% |
| Jun 30, 2018 | -1.71% |
| Mar 31, 2018 | -0.95% |
| Dec 31, 2017 | -6.60% |
| Sep 30, 2017 | 41.47% |
| Jun 30, 2017 | 6.52% |
| Mar 31, 2017 | -3.17% |
| Dec 31, 2016 | 53.56% |
| Sep 30, 2016 | 9.29% |
| Jun 30, 2016 | 20.81% |
| Mar 31, 2016 | -10.03% |
| Dec 31, 2015 | -2.21% |
| Sep 30, 2015 | -19.59% |
| Jun 30, 2015 | 30.46% |